2300-PUB: The Efficacy and Safety of Combinations of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes: A Systematic Review and Meta-analysis

Diabetes ◽

10.2337/db19-2300-pub ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 2300-PUB

Author(s):

MAN GUO ◽

JUNLING GU ◽

JINGSONG LI ◽

YONG XU

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Efficacy And Safety ◽

Receptor Agonists

Download Full-text

The efficacy and safety of combinations of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of type 2 diabetes or obese adults: a systematic review and meta-analysis

Endocrine ◽

10.1007/s12020-019-02175-6 ◽

2020 ◽

Vol 67 (2) ◽

pp. 294-304 ◽

Author(s):

Man Guo ◽

Junling Gu ◽

Fangyuan Teng ◽

Jiao Chen ◽

Xiumei Ma ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Efficacy And Safety ◽

Obese Adults ◽

Receptor Agonists

Download Full-text

GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2021.108737 ◽

2021 ◽

Vol 174 ◽

pp. 108737

Author(s):

Thomas Karagiannis ◽

Apostolos Tsapas ◽

Eleni Athanasiadou ◽

Ioannis Avgerinos ◽

Aris Liakos ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Older People ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Receptor Agonists

Download Full-text

Faculty Opinions recommendation of SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734434782.793555944 ◽

2019 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Secondary Prevention ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Cardiovascular Outcome ◽

Primary And Secondary Prevention ◽

Cardiovascular Outcome Trials ◽

Download Full-text

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(21)00203-5 ◽

2021 ◽

Author(s):

Naveed Sattar ◽

Matthew M Y Lee ◽

Søren L Kristensen ◽

Kelley R H Branch ◽

Stefano Del Prato ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Cardiovascular Mortality ◽

Meta Analysis ◽

Randomised Trials ◽

Receptor Agonists

Download Full-text

Efficacy and safety of liraglutide in type 2 diabetes mellitus patients complicated with coronary artery diseases: a systematic review and meta-analysis of randomized controlled trials

Pharmacological Research ◽

10.1016/j.phrs.2021.105765 ◽

2021 ◽

pp. 105765

Author(s):

Lidan Wang ◽

Qiqi Xin ◽

Ya Wang ◽

Zhuhong Chen ◽

Rong Yuan ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Coronary Artery Diseases ◽

Randomized Controlled

Download Full-text

The Efficacy and Safety of Acarbose compared with Voglibose in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

Journal of Molecular Biomarkers & Diagnosis ◽

10.4172/2155-9929.1000375 ◽

2018 ◽

Vol 09 (01) ◽

Author(s):

Lian Liu ◽

Song Wei Su ◽

Yong Xu ◽

Qin Wan ◽

Xiao Ling Yang ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Efficacy And Safety

Download Full-text

The efficacy and safety of SGLT2 inhibitors combined with ACEI/ARBs in the treatment of type 2 diabetes mellitus: A meta-analysis of randomized controlled studies

Expert Opinion on Drug Safety ◽

10.1080/14740338.2020.1817378 ◽

2020 ◽

Vol 19 (11) ◽

pp. 1497-1504

Author(s):

Yuwen Cai ◽

Weinan Shi ◽

Gaosi Xu

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Randomized Controlled Studies

Download Full-text

Meta‐analysis on the efficacy and safety of SGLT2 inhibitors and incretin based agents combination therapy vs. SGLT2i alone or add‐on to metformin in type 2 diabetes

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.3223 ◽

2019 ◽

Vol 36 (2) ◽

Author(s):

Yue Zhou ◽

Zhuang Geng ◽

Xiang Wang ◽

Yajing Huang ◽

Liyan Shen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Efficacy And Safety

Download Full-text

Review for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v2/review1 ◽

2020 ◽

Author(s):

Ling Li

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v1/review6 ◽

2020 ◽

Author(s):

Raquel Comoglio

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text